Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
Cefotaxime May Be Linked to Stevens Johnson Syndrome
By Jessica Tyner
Cefotaxime is a commonly-prescribed antibiotic to treat bacterial infections. It’s prescribed to all types of people around the country, from young children to the elderly. Many doctors agree that antibiotics in general are overprescribed — but there’s a bigger risk than just becoming immune to antibiotics and requiring stronger treatment year after year. SJS is a very painful and oftentimes deadly allergic reaction to a drug. It’s rare, but some drugs pose a greater risk of developing the condition. It usually begins as a rash and can easily be misdiagnosed as a skin irritant, but it can turn fatal overnight (especially in vulnerable populations like young children). Without a correct diagnosis and treatment in a burn unit, the body burns itself from the inside out and the skin begins blistering and peeling off in layers.
In the case of Cefotaxime, some users claim that they were never properly warned about the risks. Every drug has a warning label, and Cefotaxime’s includes fever, hypotension, Lyell’s Syndrome, sepsis and erythema multiforme. There was allegedly no mention of Cefotaxime SJS at all — and that’s the foundation of Cefotaxime lawsuits. SJS is so rare that most people haven’t even heard of it unless they know someone who had it. Many doctors have never seen it in person.
As of Oct. 26, 2013, 2,062 people reported Cefotaxime side effects to the FDA and 104 of those people (or 5.04 percent) reported SJS. Of course, these statistics don’t take into consideration the people who may have had SJS from the drug and either don’t know what caused it, haven’t reported it to the FDA, or those who lost their lives to it and their families have not made any formal Cefotaxime complaints. Strangely, the drug seems to play favorites, too. In total, 71.19 percent of Cefotaxime victims were male and 28.81 percent were female. The vast majority of the people were over the age of 60 at 59.48 percent, and the second largest group was aged 10-19 at 19.83 percent.
Did You Get SJS from Cefotaxime?
Were you prescribed Cefotaxime for any ailment and were then diagnosed with SJS? Or did you lose a loved one to SJS from the drug? If this happened to you, you might have a Cefotaxime legal claim. Discover more about your next steps by visiting the Stevens Johnson (SJS) & Toxic Epidermal Necrolysis (TEN) Class Action Lawsuit Investigationtoday. Submit your story and an attorney will contact you if you qualify for a complimentary Cefotaxime claim review.
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
